Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

This article contains data on clinical endpoints (Peak Flow Expiratory Rate, fractional exhaled nitric oxide and total IgE serum levels) and plasma pharmacokinetic parameters concerning the use of the oral CRTh2 antagonist QAW039 (fevipiprant) in mild to moderate asthma patients. Information on expe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Data Brief
Asıl Yazarlar: Erpenbeck, Veit J., Popov, Todor A., Miller, David, Weinstein, Steven F., Spector, Sheldon, Magnusson, Baldur, Osuntokun, Wande, Goldsmith, Paul, Weiss, Markus, Beier, Jutta
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2016
Konular:
Data Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5021787/
https://ncbi.nlm.nih.gov/pubmed/27656673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2016.08.039
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller